XML 68 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Long-Term Investments (Details) - Schedule of Balance Sheet - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
BioFirst [Member]        
Condensed Balance Sheet Statements, Captions [Line Items]        
Current Assets $ 1,690,060 $ 1,543,152 $ 1,543,152  
Non-current Assets 651,221 739,472 739,472  
Current Liabilities 2,236,708 2,663,051 2,663,051  
Non-current Liabilities 366,634 103,447 103,447  
Stockholders’ Equity (Deficit) (262,061) (483,874)    
Rgene [Member]        
Condensed Balance Sheet Statements, Captions [Line Items]        
Current Assets 56,091 68,302 68,302 $ 73,452
Non-current Assets 239,594 303,893 303,893 374,423
Current Liabilities 2,407,204 2,478,868 2,478,868 1,934,786
Non-current Liabilities 1,465 2,441 2,441
Stockholders’ Equity (Deficit) $ (2,112,984) $ (2,109,114) $ (2,481,309) $ (1,486,911)